Factors associated with intermittent preventive treatment of malaria during pregnancy in Mali
Souleymane S. Diarra1, Drissa Konate 1, Sory I. Diawara1, Mariam Tall2, Mahamadou Diakite1, and Seydou Doumbia1
1 University of Sciences Techniques and Technology of Bamako, Mali
2 National Program of Malaria Control, Bamako
Citation: Diarra SS, Konate D, Diawara SI, Tall M, Diakite M, Doumbia S (2019) Factors associated with intermittent preventive treatment of malaria during pregnancy in Mali. SciTech Immuno-Microbiology 2019. Dubai: UAE
Received: April 22, 2019 Accepted: April 23, 2019 Published: April 24, 2019
Intermittent preventive treatment in pregnancy (IPTp) with 3 or more doses of sulfadoxinepyrimethamine (SP) is recommended by the World Health Organization to prevent malaria in pregnant women living in high-risk areas. According to the 2015 malaria indicator survey in Mali, malaria prevalence is 34.6%. The high risk of malaria among pregnant women and children led the Malian government to provide free SP during antenatal clinics visits. The Malian National Program of Malaria Control recommends at least 3 doses during pregnancy. The proportion of pregnant women taking 3 or more doses of IPTp-SP (IPTp 3+) still remains low. In Mali, only 36.7% of pregnant women with a live birth in the past 2 yr received IPTp 3+. To investigate the factors associated with this low coverage, we carried out a secondary data analysis using the database of the Mali 2015 Malaria Indicator Survey. Multiple logistic regression was used to analyze these factors among 2,382 interviewed women. Taking less than 3 doses was higher among women below 20 yr (adjusted odds ratio [AOR] = 1.43, 95% conﬁdence interval [CI, 1.03; 1.98]); however, media accessibility (listening to radio) (AOR = 0.71, 95% CI [0.53–0.95]) and residing in Segou (AOR = 0.56, 95% CI [0.35–0.90]) seem to favor the opposite after adjusting the potential confusion. Residence, educational level, and wealth index were not statistically associated with taking 3 doses of IPTp-SP. This study identiﬁes that women less than 20 yr of age were signiﬁcantly associated with taking lower than 3 doses of IPTp-SP.
KEY WORDS Malaria, Pregnancy, ANC IPTp-SP